argenx (ARGX) Competitors

GSK (NYSE:GSK) and argenx (NASDAQ:ARGX) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, media sentiment, analyst recommendations, profitability, earnings, valuation, dividends, institutional ownership and risk.

Which has more volatility and risk, GSK or ARGX?

GSK has a beta of 0.58, meaning that its share price is 42% less volatile than the S&P 500. Comparatively, argenx has a beta of 0.59, meaning that its share price is 41% less volatile than the S&P 500.

Do analysts rate GSK or ARGX?

GSK presently has a consensus price target of $43.25, suggesting a potential upside of 12.09%. argenx has a consensus price target of $687.00, suggesting a potential upside of 13.00%. Given argenx's stronger consensus rating and higher probable upside, analysts plainly believe argenx is more favorable than GSK.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GSK	0 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	3 Strong Buy rating(s)	2.60
argenx	0 Sell rating(s)	3 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.91

Do insiders and institutionals believe in GSK or ARGX?

15.7% of GSK shares are owned by institutional investors. Comparatively, 60.3% of argenx shares are owned by institutional investors. 10.0% of GSK shares are owned by insiders. Comparatively, 2.4% of argenx shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Is GSK or ARGX more profitable?

GSK has a net margin of 8.13% compared to argenx's net margin of -2.11%. GSK's return on equity of 48.59% beat argenx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GSK	8.13%	48.59%	11.11%
argenx	-2.11%	-1.45%	-1.29%

Does the MarketBeat Community believe in GSK or ARGX?

GSK received 168 more outperform votes than argenx when rated by MarketBeat users. However, 67.28% of users gave argenx an outperform vote while only 57.12% of users gave GSK an outperform vote.

Company	Underperform	Outperform
GSK	Outperform Votes 822 57.12%	Underperform Votes 617 42.88%
argenx	Outperform Votes 654 67.28%	Underperform Votes 318 32.72%

Does the media prefer GSK or ARGX?

In the previous week, GSK had 29 more articles in the media than argenx. MarketBeat recorded 54 mentions for GSK and 25 mentions for argenx. argenx's average media sentiment score of 1.04 beat GSK's score of 0.31 indicating that argenx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GSK	21 Very Positive mention(s)	6 Positive mention(s)	20 Neutral mention(s)	4 Negative mention(s)	3 Very Negative mention(s)	Neutral
argenx	12 Very Positive mention(s)	0 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has higher earnings & valuation, GSK or ARGX?

GSK has higher revenue and earnings than argenx. GSK is trading at a lower price-to-earnings ratio than argenx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GSK	$31.38B	2.55	$3.29B	$1.59	24.27
argenx	$2.19B	16.87	-$295.05M	$12.59	48.29

Summary

GSK beats argenx on 10 of the 19 factors compared between the two stocks.